MedPath

A Clinical Study Assessing the Potential of Piboserod for the Treatment of Heart Failure

Phase 2
Completed
Conditions
Congestive Heart Failure
Registration Number
NCT00421746
Lead Sponsor
Bio-Medisinsk Innovasjon
Brief Summary

The purpose of this study is to determine whether piboserod, a serotonin-4 receptor antagonist, is effective for the treatment of patients with congestive heart failure.

Detailed Description

Despite intensive research for decades, mortality and morbidity in chronic heart failure remains quite high. There is an obvious need for new drugs, especially drugs which may have a different mode of action than the existing ones on the market.

The purpose of this trial is to evaluate whether a new drug candidate, piboserod, has beneficial biological effects in stable outpatients with symptomatic heart failure receiving evidence based treatment for heart failure and to assess safety and tolerability of this treatment.

Recruitment & Eligibility

Status
COMPLETED
Sex
All
Target Recruitment
137
Inclusion Criteria
  • Clinical diagnosis of CHF (NYHA class II-IV)
  • Locally determined LVEF < 0.35 (by CMR, echocardiography, LV angiography, or radionuclide cardioangiography)
  • Stable sinus rhythm
  • Stable evidence based pharmacological treatment for CHF.
Exclusion Criteria
  • Unstable patients hospitalised within last 2 weeks
  • Baseline prolongation of QTc interval
  • Atrial fibrillation at randomisation
  • MI or re-vascularisation last 3 months
  • Stroke last 3 months.

Study & Design

Study Type
INTERVENTIONAL
Study Design
PARALLEL
Primary Outcome Measures
NameTimeMethod
Change from baseline to end-of-therapy in Left Ventricular Ejection Fraction, as measured using CMR imaging6 months
Secondary Outcome Measures
NameTimeMethod
Change in LV systolic and diastolic volume (and/or diameter) by CMR6 months
Change in NYHA functional class6 months
Change in various biomarkers for heart failure6 months
Change in QoL-scores6 months
Change in 6-minute walk distance6 months

Trial Locations

Locations (17)

Fana Hjertesenter

πŸ‡³πŸ‡΄

Nesttun, Norway

UllevΓ₯l Universitetssykehus

πŸ‡³πŸ‡΄

Oslo, Norway

Stavanger Universitetssjukehus

πŸ‡³πŸ‡΄

Stavanger, Norway

Rikshospitalet

πŸ‡³πŸ‡΄

Oslo, Norway

St. Olavs Hospital

πŸ‡³πŸ‡΄

Trondheim, Norway

Svendborg Sygehus

πŸ‡©πŸ‡°

Svendborg, Denmark

Frederiksberg Hospital

πŸ‡©πŸ‡°

Frederiksberg, Denmark

Odense Universitets Hospital

πŸ‡©πŸ‡°

Odense, Denmark

Amager Hospital

πŸ‡©πŸ‡°

Copenhagen, Denmark

Western Infirmary

πŸ‡¬πŸ‡§

Glasgow, United Kingdom

Østlandske Hjertesenter

πŸ‡³πŸ‡΄

Moss, Norway

Rigshospitalet

πŸ‡©πŸ‡°

Copenhagen, Denmark

Amtsygehuset i Herlev

πŸ‡©πŸ‡°

Herlev, Denmark

Hvidovre Hospital

πŸ‡©πŸ‡°

Hvidovre, Denmark

Bridlington and District General Hospital

πŸ‡¬πŸ‡§

Bridlington, United Kingdom

Bispebjerg Hospital

πŸ‡©πŸ‡°

Copenhagen, Denmark

Castel Hill Hospital

πŸ‡¬πŸ‡§

Cottingham, East Yorkshire, United Kingdom

Β© Copyright 2025. All Rights Reserved by MedPath